White Marvin L
Insider CIK 1493324 · CLCD Director · EBS Director · WPG Director · APVO President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 1,666 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 1,666 | — | $0 | 1,667 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2026-08-06 | 2026-08-10 | 406 | $4.07 | $1.7K | 1,261 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 1,666 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2026-08-06 | 2026-08-10 | 406 | $4.07 | $1.7K | 1,261 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 1,666 | — | — | 1,667 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-07-17 | 2026-08-10 | 1 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-07-17 | 2026-08-10 | 1 | — | $0 | 1 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2026-07-17 | 2026-08-10 | 1 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2026-07-17 | 2026-08-10 | 1 | — | — | 1 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2026-04-30 | 2026-05-04 | 11,296 | — | $0 | 11,296 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2026-04-30 | 2026-05-04 | 25,344 | — | $0 | 113,839 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2025-08-06 | 2025-08-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-07-17 | 2025-07-21 | 10 | — | $0 | 20 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-07-17 | 2025-07-21 | 10 | — | $0 | 12 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2025-04-30 | 2025-05-02 | 15,824 | — | $0 | 41,572 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2025-04-30 | 2025-05-02 | 34,403 | — | $0 | 88,495 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-03-03 | 2025-03-04 | 6 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-03-03 | 2025-03-04 | 6 | — | $0 | 55 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2025-03-02 | 2025-03-04 | 8 | — | $0 | 8 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2025-03-02 | 2025-03-04 | 8 | — | $0 | 49 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2024-11-11 | 2024-11-13 | 14,287 | $11.97 | $171.0K | 54,092 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2024-07-17 | 2024-07-19 | 22,325 | — | $0 | 22,325 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 25,748 | — | $0 | 25,748 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2024-05-23 | 2024-05-28 | 17,430 | — | $0 | 68,379 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-03-03 | 2024-03-05 | 9,584 | — | $0 | 9,584 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-03-03 | 2024-03-05 | 9,584 | — | $0 | 67,430 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-03-02 | 2024-03-05 | 12,917 | — | $0 | 25,833 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-03-02 | 2024-03-05 | 12,917 | — | $0 | 57,846 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2024-01-28 | 2024-01-30 | 4,792 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2024-01-28 | 2024-01-30 | 4,792 | — | $0 | 44,929 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2023-05-25 | 2023-05-30 | 33,847 | — | $0 | 50,949 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-03-03 | 2023-03-07 | 38,750 | — | $0 | 38,750 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2023-03-03 | 2023-03-07 | 38,750 | — | $0 | 38,750 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-03-03 | 2023-03-07 | 9,582 | — | $0 | 19,168 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-03-03 | 2023-03-07 | 9,582 | — | $0 | 40,137 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2023-01-29 | 2023-01-30 | 4,791 | — | $0 | 4,792 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2023-01-29 | 2023-01-30 | 4,791 | — | $0 | 30,555 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-06-07 | 2022-06-07 | 28,750 | — | $0 | 28,750 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2022-05-26 | 2022-05-31 | 8,446 | — | $0 | 17,102 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2022-03-04 | 2022-03-04 | 28,750 | — | $0 | 28,750 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2022-01-29 | 2022-02-01 | 4,792 | — | $0 | 9,583 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2022-01-29 | 2022-02-01 | 4,792 | — | $0 | 25,764 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2021-05-20 | 2021-05-24 | 5,027 | — | $0 | 8,656 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-01-29 | 2021-02-17 | 43,125 | — | $0 | 43,125 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2021-01-29 | 2021-02-17 | 14,375 | — | $0 | 14,375 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2020-10-01 | 2020-10-05 | 3,629 | — | $0 | 3,629 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 10,828 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 2,545 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 14,319 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 5,414 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 5,414 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | D To issuer deriv | 2020-07-27 | 2020-07-29 | 10,828 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 16,625 | — | $0 | 16,625 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-07-27 | 2020-07-29 | 4,813 | — | $0 | 4,813 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2020-02-18 | 2020-03-19 | 303,200 | — | $0 | 303,200 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-11-01 | 2019-11-05 | 189,894 | — | $0 | 189,894 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-06-14 | 2019-06-14 | 50,000 | $0.88 | $44.0K | 293,603 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-05-20 | 2019-05-20 | 30,000 | $0.81 | $24.3K | 243,603 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2019-05-14 | 2019-05-14 | 10,000 | $0.78 | $7.8K | 213,603 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2019-02-28 | 2019-03-04 | 151,600 | — | $0 | 151,600 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2018-12-04 | 2018-12-06 | 10,000 | $2.38 | $23.8K | 203,603 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2018-05-21 | 2018-05-23 | 35,644 | — | $0 | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | F Tax w/h | 2018-05-21 | 2018-05-23 | 8,373 | $5.61 | $47.0K | 193,603 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2018-05-21 | 2018-05-23 | 35,644 | — | $0 | 201,976 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | S Sale | 2018-03-19 | 2018-03-21 | 100,000 | $2.93 | $293.0K | 166,332 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | P Buy | 2018-03-19 | 2018-03-21 | 100,000 | $2.93 | $293.0K | 166,332 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2018-03-09 | 2018-03-13 | 151,600 | — | $0 | 151,600 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-06-01 | 2017-06-01 | 75,800 | — | $0 | 75,800 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-05-22 | 2017-05-23 | 35,643 | — | $0 | 53,472 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise deriv | 2017-05-22 | 2017-05-23 | 17,828 | — | $0 | 35,644 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-05-22 | 2017-05-23 | 17,828 | — | $0 | 66,332 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | M Exercise | 2017-05-22 | 2017-05-23 | 35,643 | — | $0 | 48,504 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | D To issuer deriv | 2017-03-01 | 2017-03-01 | 6,577 | $37.90 | $249.3K | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | D To issuer deriv | 2017-03-01 | 2017-03-01 | 997 | $38.00 | $37.9K | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | D To issuer deriv | 2017-03-01 | 2017-03-01 | 8,897 | $40.26 | $358.2K | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | D To issuer deriv | 2017-03-01 | 2017-03-01 | 1,630 | $36.88 | $60.1K | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | D To issuer deriv | 2017-03-01 | 2017-03-01 | 453 | $10.30 | $4.7K | 0 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2017-02-24 | 2017-02-27 | 75,800 | — | $0 | 311,918 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2017-01-03 | 2017-01-04 | 453 | $30.35 | $13.7K | 453 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-08-05 | 200,475 | — | $0 | 200,475 | SEC↗ |
| APVO Aptevo Therapeutics Inc. | A Award deriv | 2016-08-03 | 2016-09-27 | 200,475 | — | $0 | 236,118 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2016-07-01 | 2016-07-05 | 1,630 | $8.44 | $13.8K | 1,630 | SEC↗ |
| EBS Emergent BioSolutions Inc. | D To issuer | 2016-05-18 | 2016-05-20 | 7,833 | — | $0 | 22,467 | SEC↗ |
| EBS Emergent BioSolutions Inc. | D To issuer | 2016-05-18 | 2016-05-23 | 7,833 | — | $0 | 30,300 | SEC↗ |
| WPG WP Glimcher Inc. | A Award deriv | 2016-05-17 | 2016-05-19 | 12,060 | — | $0 | 12,060 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2016-05-10 | 2016-05-12 | 8,897 | — | $0 | 8,897 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-03-07 | 2016-03-09 | 4,800 | — | $0 | 2,400 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-03-07 | 2016-03-09 | 3,134 | — | $0 | 6,266 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-03-07 | 2016-03-09 | 10,800 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-03-07 | 2016-03-09 | 7,200 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise deriv | 2016-03-07 | 2016-03-09 | 7,200 | — | $0 | 0 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-03-07 | 2016-03-09 | 7,200 | $14.66 | $105.6K | 37,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-03-07 | 2016-03-09 | 7,200 | $35.42 | $255.0K | 30,300 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-03-07 | 2016-03-09 | 7,200 | $22.02 | $158.5K | 37,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-03-07 | 2016-03-09 | 7,200 | $35.42 | $255.0K | 30,300 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-03-07 | 2016-03-09 | 4,800 | $14.25 | $68.4K | 35,100 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-03-07 | 2016-03-09 | 4,800 | $35.42 | $170.0K | 30,300 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-03-07 | 2016-03-09 | 3,134 | $20.44 | $64.1K | 33,434 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-03-07 | 2016-03-09 | 3,134 | $35.42 | $111.0K | 30,300 | SEC↗ |
| EBS Emergent BioSolutions Inc. | S Sale | 2016-03-07 | 2016-03-09 | 10,800 | $35.42 | $382.5K | 30,300 | SEC↗ |
| EBS Emergent BioSolutions Inc. | M Exercise | 2016-03-07 | 2016-03-09 | 10,800 | $15.75 | $170.1K | 41,100 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2016-01-04 | 2016-01-06 | 997 | $6.90 | $6.9K | 997 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | A Award deriv | 2015-07-09 | 2015-07-13 | 6,577 | — | $0 | 6,577 | SEC↗ |
| WPG WP Glimcher Inc. | P Buy | 2015-06-22 | 2015-06-23 | 3,500 | $14.20 | $49.7K | 5,000 | SEC↗ |
| WPG WP Glimcher Inc. | P Buy | 2015-06-19 | 2015-06-23 | 1,500 | $14.30 | $21.4K | 1,500 | SEC↗ |
| WPG WP Glimcher Inc. | A Award deriv | 2015-05-21 | 2015-05-26 | 8,403 | — | $0 | 8,403 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2015-05-21 | 2015-05-21 | 9,400 | — | $0 | 30,300 | SEC↗ |
| WPG Washington Prime Group Inc | A Award deriv | 2014-08-04 | 2014-08-06 | 6,380 | — | $0 | 6,380 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2014-05-22 | 2014-05-23 | 9,400 | — | $0 | 9,400 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2014-05-22 | 2014-05-23 | 4,700 | — | $0 | 20,900 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2013-05-23 | 2013-05-24 | 7,200 | — | $0 | 7,200 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2013-05-23 | 2013-05-24 | 3,600 | — | $0 | 16,200 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2012-05-17 | 2012-05-21 | 7,200 | — | $0 | 7,200 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2012-05-17 | 2012-05-21 | 3,600 | — | $0 | 12,600 | SEC↗ |